KCG
WINT

Knight Capital Group’s Windtree Therapeutics Inc WINT Stock Holding History

Knight Capital Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$50K Buy
+2,379
New +$58.6K ﹤0.01% 3062

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Knight Capital Group's WINT Position: Q2 2013 in Review

Knight Capital Group opened a new position in Windtree Therapeutics Inc (WINT) in Q2 2013: 2,379 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #3062 among its holdings.

64 funds tracked by Wall St. Rank hold WINT as of Q2 2013.

  • Knight Capital Group held 2,379 shares of Windtree Therapeutics Inc worth $50K as of Q2 2013.
  • Windtree Therapeutics Inc was a new Knight Capital Group position in Q2 2013.
  • Windtree Therapeutics Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3062 holding.
  • 64 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.